Drug ID: | NPD5426 |
Drug Name: | Tivantinib |
Molecular Formula: | C23H19N3O2 |
Canonical SMILES: | OC1=NC(=O)[C@H]([C@@H]1c1c[nH]c2c1cccc2)c1cn2c3c1cccc3CCC2 |
Standard InCHI: | InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1 |
Standard InCHIKey: | UCEQXRCJXIVODC-PMACEKPBSA-N |
Max Developmental Stage: | Phase 3 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DCL000052; DNCL002130 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 11494412 |
ChEBI | |
CAS Number |
Molecular Weight | 369.15 |
ALogP | -1.7619 |
MLogP | 3.44 |
XLogP | 3.72 |
HDA | 5 |
HBD | 2 |
Rotatable Bonds | 3 |
TPSA | 70.38 |
RO5 Violation | 0 |